Norton, N.J.; Ings, D.P.; Fifield, K.E.; Barnes, D.A.; Barnable, K.A.; Harnum, D.O.A.; Holder, K.A.; Russell, R.S.; Grant, M.D.
Characteristics of Vaccine- and Infection-Induced Systemic IgA Anti-SARS-CoV-2 Spike Responses. Vaccines 2023, 11, 1462.
https://doi.org/10.3390/vaccines11091462
AMA Style
Norton NJ, Ings DP, Fifield KE, Barnes DA, Barnable KA, Harnum DOA, Holder KA, Russell RS, Grant MD.
Characteristics of Vaccine- and Infection-Induced Systemic IgA Anti-SARS-CoV-2 Spike Responses. Vaccines. 2023; 11(9):1462.
https://doi.org/10.3390/vaccines11091462
Chicago/Turabian Style
Norton, Natasha J., Danielle P. Ings, Kathleen E. Fifield, David A. Barnes, Keeley A. Barnable, Debbie O. A. Harnum, Kayla A. Holder, Rodney S. Russell, and Michael D. Grant.
2023. "Characteristics of Vaccine- and Infection-Induced Systemic IgA Anti-SARS-CoV-2 Spike Responses" Vaccines 11, no. 9: 1462.
https://doi.org/10.3390/vaccines11091462
APA Style
Norton, N. J., Ings, D. P., Fifield, K. E., Barnes, D. A., Barnable, K. A., Harnum, D. O. A., Holder, K. A., Russell, R. S., & Grant, M. D.
(2023). Characteristics of Vaccine- and Infection-Induced Systemic IgA Anti-SARS-CoV-2 Spike Responses. Vaccines, 11(9), 1462.
https://doi.org/10.3390/vaccines11091462
